IPSEN (EPA:IPN) | Finanzwire

Basculer en Français

9473	Companies
185387	Keywords
117733	Articles
99269	Press releases

Home
Companies
IPSEN

PRESS RELEASE

published on 09/16/2024 at 14:45, 1 year 2 months ago

Final results from CABINET Phase III trial reinforce efficacy benefits of Cabometyx® in advanced neuroendocrine tumors
Final results from CABINET Phase III trial show significant reduction in disease progression or death risk with Cabometyx in advanced neuroendocrine tumors. Data presented at ESMO 2024 and NEJM

Phase III Trial Neuroendocrine Tumors ESMO 2024 Cabometyx Disease Progression
BRIEF

published on 09/15/2024 at 14:50, 1 year 2 months ago

New analysis of the CONTACT-02 trial by Ipsen

Clinical Trial Ipsen Prostate Cancer CONTACT-02 Cabometyx
PRESS RELEASE

published on 08/13/2024 at 18:00, 1 year 3 months ago

IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2024
BRIEF

published on 05/28/2024 at 07:05, 1 year 6 months ago

Ipsen Proposes Share Repurchase Program at Annual General Meeting

Annual General Meeting French Commercial Code Share Repurchase Stock Buyback Ipsen
BRIEF

published on 05/28/2024 at 07:05, 1 year 6 months ago

Ipsen Announces Share Repurchase Program Details

Annual General Meeting Share Repurchase Corporate Governance Investment Stock Buyback
PRESS RELEASE

published on 05/28/2024 at 07:00, 1 year 6 months ago

Description of the regulatory framework of the share repurchase program proposed by the Board of Directors to be approved at Ipsen S.A.’s Annual General Meeting on 28 May 2024
Ipsen S.A. presents the regulatory framework of the share repurchase program proposed at the Annual General Meeting on 28 May 2024, covering objectives, characteristics, maximum repurchase amount, price, and duration

Annual General Meeting Share Repurchase Program Regulatory Framework Ipsen S.A. Maximum Repurchase Price
BRIEF

published on 05/07/2024 at 15:00, 1 year 6 months ago

Ipsen S.A. Announces Details for 2024 Annual General Meeting

Board Of Directors Annual General Meeting Regulatory Compliance Dividend Ipsen S.A.
PRESS RELEASE

published on 05/07/2024 at 14:55, 1 year 6 months ago

Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2024 Annual General Meeting
Ipsen S.A. to hold Combined Shareholders’ Meeting on 28 May 2024, revealing resolutions including dividend payment & appointment renewals. Documents available for shareholder review

Dividend Payment Ipsen S.A. Combined Shareholders’ Meeting Appointment Renewals Shareholder Review

Accesswire

Published on 12/05/2025 at 02:35, 5 hours 37 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 5 hours 42 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 7 hours 12 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 7 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 12 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 08:05, 7 minutes ago

Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 11 minutes ago

Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 11 minutes ago

Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025
Published on 12/05/2025 at 08:00, 12 minutes ago

Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing
Published on 12/05/2025 at 07:00, 1 hour 12 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business

Les Echos

Published on 12/04/2025 at 18:00, 14 hours 12 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 27 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 28 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 14 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE